• / Free eNewsletters & Magazine
  • / My Account
Home>Illumina Profit Drops Amid Climbing Expenses

Illumina Profit Drops Amid Climbing Expenses

3party Content

Tue, 3 May 2016

Genetic-sequencing company Illumina Inc. posted a 34% decline in profit for its first quarter amid climbing expenses. Expenses rose 39% to $276 million, with research and development expenses climbing to $124 million from $91.8 million in the prior-year period. On the heels of the latest results,
Upcoming Events

©2014 Morningstar Advisor. All right reserved.